Published in Biochem J on August 01, 2001
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Structural relationships between clathrin assembly proteins from the Golgi and the plasma membrane. EMBO J (1988) 4.06
Sequences within and adjacent to the transmembrane segment of alpha-2,6-sialyltransferase specify Golgi retention. EMBO J (1991) 2.91
An investigation of the role of transmembrane domains in Golgi protein retention. EMBO J (1995) 2.71
Kin recognition between medial Golgi enzymes in HeLa cells. EMBO J (1994) 2.62
Overlapping distribution of two glycosyltransferases in the Golgi apparatus of HeLa cells. J Cell Biol (1993) 2.50
GTP hydrolysis by arf-1 mediates sorting and concentration of Golgi resident enzymes into functional COP I vesicles. EMBO J (1999) 2.30
Localization of proteins to the Golgi apparatus. Trends Cell Biol (1998) 2.05
Detergent binding as a measure of hydrophobic surface area of integral membrane proteins. J Biol Chem (1993) 2.03
Multi-protein complexes in the cis Golgi of Saccharomyces cerevisiae with alpha-1,6-mannosyltransferase activity. EMBO J (1998) 1.91
A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase. Genes Dev (1990) 1.84
PtK1 cells contain a nondiffusible, dominant factor that makes the Golgi apparatus resistant to brefeldin A. J Cell Biol (1991) 1.74
Organelle pH studies using targeted avidin and fluorescein-biotin. Chem Biol (2000) 1.64
Decoding of sorting signals by coatomer through a GTPase switch in the COPI coat complex. Cell (2000) 1.56
Mutational analysis of the Golgi retention signal of bovine beta-1,4-galactosyltransferase. J Biol Chem (1993) 1.44
Golgi retention mechanism of beta-1,4-galactosyltransferase. Membrane-spanning domain-dependent homodimerization and association with alpha- and beta-tubulins. J Biol Chem (1995) 1.33
Receptor-mediated targeting of fluorescent probes in living cells. J Biol Chem (1999) 1.30
Mechanisms of protein sorting and coat assembly: insights from the clathrin-coated vesicle pathway. Curr Opin Cell Biol (1998) 1.24
Medial Golgi but not late Golgi glycosyltransferases exist as high molecular weight complexes. Role of luminal domain in complex formation and localization. J Biol Chem (2000) 1.19
Determinants of the pH of the Golgi complex. J Biol Chem (2000) 1.15
Breaking the COPI monopoly on Golgi recycling. Trends Cell Biol (2000) 1.11
Accumulation of misfolded protein aggregates leads to the formation of russell body-like dilated endoplasmic reticulum in yeast. Yeast (1997) 0.93
GM3 alpha2,8-sialyltransferase (GD3 synthase): protein characterization and sub-golgi location in CHO-K1 cells. J Neurochem (2000) 0.92
Control of glycoprotein synthesis. Purification of UDP-N-acetylglucosamine:alpha-D-mannoside beta 1-2 N-acetylglucosaminyltransferase II from rat liver. J Biol Chem (1987) 0.91
Localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase to the trans-Golgi network. Biochem J (1997) 0.88
Size exclusion chromatography and universal calibration of gel columns. Anal Biochem (1989) 0.88
Formation of insoluble oligomers correlates with ST6Gal I stable localization in the golgi. J Biol Chem (2000) 0.88
Stable expression of the Golgi form and secretory variants of human fucosyltransferase III from BHK-21 cells. Purification and characterization of an engineered truncated form from the culture medium. J Biol Chem (1997) 0.86
Trafficking and localization studies of recombinant alpha1, 3-fucosyltransferase VI stably expressed in CHO cells. Glycobiology (1998) 0.84
Expression and characterization of recombinant human alpha-3/4-fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system. Biochem J (2001) 0.77
Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A (1992) 5.94
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst (2001) 5.09
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res (1996) 3.74
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol (1997) 3.60
Tissue microarray: a new technology for amplification of tissue resources. Cancer J (2001) 3.19
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet (1989) 2.94
A database of vertebrate longevity records and their relation to other life-history traits. J Evol Biol (2009) 2.93
Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? Am J Trop Med Hyg (2000) 2.18
Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med (2000) 2.05
Extraskeletal Ewing's sarcoma: results of combined modality treatment. J Clin Oncol (1983) 1.99
The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer (1984) 1.93
Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2003) 1.91
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med (1982) 1.83
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med (1982) 1.67
Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med (1998) 1.63
[Health inequalities in Barcelona and Valencia]. Med Clin (Barc) (1993) 1.61
Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer (1992) 1.56
Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg (1977) 1.55
Combined small-cell and transitional cell carcinoma of the renal pelvis. A light microscopic, immunohistochemical, and ultrastructural study of a case with literature review. Arch Pathol Lab Med (1993) 1.53
Immunoglobulin binding to herpes virus-induced Fc receptors inhibits virus growth. Nature (1977) 1.50
Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet (1995) 1.49
Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ (1999) 1.46
Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology (1993) 1.44
Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection. J Viral Hepat (2006) 1.40
An efficient locally affine framework for the smooth registration of anatomical structures. Med Image Anal (2008) 1.38
Diamine oxidase from pig kidney. Improved purification and properties. J Biol Chem (1967) 1.38
Characteristics of the Fc receptor induced by herpes simplex virus. Intervirology (1978) 1.38
Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A (1994) 1.36
Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res (1995) 1.33
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery (1985) 1.30
Gastric dysplasia. A histological follow-up study. Am J Surg Pathol (1987) 1.28
Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med (1983) 1.27
Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry (1997) 1.27
Properties of the cell surface Fc-receptor induced by herpes simplex virus. J Immunol (1978) 1.26
Idiopathic entero-colic lymphocytic phlebitis. A cause of ischemic intestinal necrosis. Am J Surg Pathol (1989) 1.23
Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery (1978) 1.23
Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis (2006) 1.23
K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol (1994) 1.23
Presence of human papilloma viral antigens in juvenile multiple laryngeal papilloma. Am J Clin Pathol (1981) 1.22
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol (1997) 1.19
Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients. Clin Rheumatol (2009) 1.19
On the nature of chromophore in pig kidney diamine oxidase. Eur J Biochem (1977) 1.18
Crystal structure of plant aspartic proteinase prophytepsin: inactivation and vacuolar targeting. EMBO J (1999) 1.18
High-grade soft tissue sarcomas of the extremities. Cancer (1986) 1.18
Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol (1999) 1.15
Histopathology of bone marrow in human immunodeficiency virus infection. Virchows Arch A Pathol Anat Histopathol (1987) 1.14
Selective degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem (2001) 1.14
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer (1983) 1.14
Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J Clin Psychiatry (1994) 1.14
Idiopathic midline destructive disease (IMDD): a subgroup of patients with the "midline granuloma" syndrome. Am J Clin Pathol (1982) 1.14
Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol (1996) 1.14
[Role of hepatitis C virus in porphyria cutanea tarda hepatopathy]. Med Clin (Barc) (1996) 1.13
Identification of the human Lewis(a) carbohydrate motif in a secretory peroxidase from a plant cell suspension culture (Vaccinium myrtillus L.). FEBS Lett (1997) 1.12
Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial. Int J Clin Pharmacol Ther (2006) 1.12
Hepatocellular carcinoma with carcinoid features. Hum Pathol (1984) 1.11
Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol (1991) 1.10
Granting diploma RNs credit would benefit profession. Am Nurse (1997) 1.09
Mixed anaplastic small-cell and squamous-cell carcinoma of the lung. Ann Intern Med (1978) 1.09
Results of reoperation for persistent and recurrent hyperparathyroidism. Ann Surg (1981) 1.09
Diamine oxidase inactivation by hydrogen peroxide. Biochim Biophys Acta (1967) 1.08
Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. Int J Biochem Cell Biol (2009) 1.08
Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Exp Parasitol (1996) 1.08
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology (1999) 1.08
Highly sensitive nonradioactive single-strand conformational polymorphism. Detection of Ki-ras mutations. Diagn Mol Pathol (1996) 1.07
Advanced ovarian cancer: correlation of histologic grade with response to therapy and survival. Cancer (1980) 1.07
Small-cell osteosarcoma. Cancer (1982) 1.07
Reoperative parathyroid surgery. Am J Surg (1975) 1.07
Occurrence of Ki-ras and p53 mutations in primary colorectal tumors. Oncogene (1991) 1.06
NIH consensus development statement on management of hepatitis B. NIH Consens State Sci Statements (2009) 1.06
Transforming growth factor-beta in human cutaneous leishmaniasis. Am J Pathol (1995) 1.05
Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc Natl Acad Sci U S A (1997) 1.05
Pyridoxal phosphate as a prosthetic group of pig kidney diamine oxidase. Arch Biochem Biophys (1967) 1.05
The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis (1995) 1.05
Hamster ependymomas produced by intracerebral inoculation of a human papovavirus (MMV). J Natl Cancer Inst (1976) 1.05
Deciphering morphology in Triatominae: the evolutionary signals. Acta Trop (2008) 1.03
Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms. Diagn Mol Pathol (1995) 1.03
A passive hemagglutination test for diagnosis of trench fever due to Rochalimaea quintana. J Infect Dis (1976) 1.02
N:NIH(S)-nu/nu mice with combined immunodeficiency: a new model for human tumor heterotransplantation. J Natl Cancer Inst (1980) 1.02
Isolation of flavonoids and a chalcone from Helichrysum odoratissimum and synthesis of helichrysetin. J Nat Prod (1989) 1.01
Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol (2001) 1.01
Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest (1993) 1.00
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers. Antimicrob Agents Chemother (1996) 0.99
Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol (1998) 0.99
The parathyroid glands in familial hypocalciuric hypercalcemia. Hum Pathol (1981) 0.98
Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma. Cancer (1981) 0.98
Ovine Echinococcus granulosus transmission dynamics in the province of Rio Negro, Argentina, 1980-1999. Vet Parasitol (2001) 0.97
Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev (1997) 0.97
Rapid, efficient genotyping of clinical tumor samples by laser-capture microdissection/PCR/SSCP. Exp Mol Pathol (2001) 0.96
[Salmonella typhi osteomyelitis]. Med Clin (Barc) (1983) 0.96
Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B. J Hepatol (1988) 0.96
Effect of dexamethasone on herpes simplex virus type 2 infection in vitro. Nature (1974) 0.96
Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. Nephrol Dial Transplant (1997) 0.96
Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol (1992) 0.95
Hepatitis C virus compartmentalization and infection recurrence after liver transplantation. Am J Transplant (2009) 0.94
Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology (2000) 0.94
Immunohistochemical study of alveolar and embryonal rhabdomyosarcoma. Lab Invest (1983) 0.93